Quorum Review was founded in 1992 by a small group of individuals who had accumulated a wealth of experience in clinical research human participant protection. Quorum’s founders believed an IRB could strive to protect human participants without giving up a focus on customer service.
Quorum Review IRB’s Mission:
The ethical protection of research participants and facilitation of the clinical research process.
Quorum Review IRB’s core values:
- Ethical Protection of Human Research Subjects
- Customer Service
- Promotion of Organizational Capability
- Continuous Quality Improvement
The first Quorum Review Board meetings were conducted in a basement around a card table, but the model became so successful that within a few years they moved into an office building and hired staff to manage their growing business.
Quorum’s focus on eliminating the impression that IRB review was the most difficult and time consuming process of clinical research has allowed Quorum to make many changes to the review process that streamlined and facilitated ethics review. Quorum began surveying the sponsors, CROs and sites and incorporated their recommendations into future offerings.
In 2006 Quorum was among the first, if not the first, IRB to introduce the concept of a secure internet portal as a means of securely submitting and receiving information quickly to and from Quorum Review.
In 2007, Quorum established a North American Board to review studies that have sites in Canada. This gave Quorum the ability to extend their review services to all of North America. Additionally, in this year, Quorum expanded the portal to include all Board Correspondence.
Quorum continued to expand service offerings in 2008 to include review of publicly funded studies as well as conducting IRB exemption determinations, grant review and review of generic participant recruitment materials.
In 2013, we began offering review of international clinical trials outside the U.S. and Canada.
Most recently, Quorum introduced a Phase I Healthy comprehensive program that offers accelerated review and more services to address the unique needs of Phase I studies. Quorum continues to focus on industry demands by continually improving processes, turnaround times and quality.
Quorum Review IRB is registered with the United States Department of Health and Human Services (DHHS) Office for Human Research Protections (OHRP) and with the Food and Drug Administration (FDA) with registration number IRB 00003226.